Elkfork Partners’s Gilead Sciences GILD Stock Holding History

Elkfork Partners’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$11.9M	Buy	187,880 +39,984	+27%	+$2.61M	0.29%	73
2019 Q2	$9.99M	Buy	147,896 +26,880	+22%	+$1.77M	0.24%	88
2019 Q1	$7.87M	Buy	121,016 +9,156	+8%	+$609K	0.2%	102
2018 Q4	$7M	Sell	111,860 -4,592	-4%	-$321K	0.2%	106
2018 Q3	$8.99M	Sell	116,452 -281,400	-71%	-$21.3M	0.21%	106
2018 Q2	$28.2M	Sell	397,852 -3,332	-0.8%	-$235K	0.73%	31
2018 Q1	$30.2M	Buy	401,184 +89,824	+29%	+$7.14M	0.82%	25
2017 Q4	$22.3M	Sell	311,360 -7,252	-2%	-$551K	0.6%	38
2017 Q3	$25.8M	Sell	318,612 -34,356	-10%	-$2.63M	0.75%	34
2017 Q2	$25M	Sell	352,968 -147,280	-29%	-$9.8M	0.75%	33
2017 Q1	$34M	Sell	500,248 -384,384	-43%	-$27M	1.04%	21
2016 Q4	$63.3M	Buy	+884,632	New	+$65.8M	2.08%	8

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Elkfork Partners's GILD Position: Q3 2019 in Review

Elkfork Partners increased its Gilead Sciences (GILD) stake by 27% in Q3 2019, buying an estimated $2.61M and bringing the position to 187,880 shares worth $11.9M. The position accounts for 0.29% of the portfolio, ranked #73.

Elkfork Partners first reported a position in GILD in Q4 2016 and has held it in 12 quarters since. The position peaked at $63.3M in Q4 2016. 1,463 funds tracked by Wall St. Rank hold GILD as of Q3 2019.

Elkfork Partners held 187,880 shares of Gilead Sciences worth $11.9M as of Q3 2019.
Elkfork Partners bought 39,984 Gilead Sciences shares in Q3 2019, an estimated $2.61M.
Gilead Sciences made up 0.29% of Elkfork Partners's portfolio in Q3 2019, its #73 holding.
Elkfork Partners first reported a position in Gilead Sciences in Q4 2016 and has held it in 12 quarters since.
Elkfork Partners's Gilead Sciences position peaked at $63.3M in Q4 2016.
1,463 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2019.

Based on Elkfork Partners's 13F filing for Q3 2019, filed 14 Nov 2019.